Metabolic remodelling of the failing heart: beneficial or detrimental?
- PMID: 18854380
- DOI: 10.1093/cvr/cvn282
Metabolic remodelling of the failing heart: beneficial or detrimental?
Abstract
The failing heart is characterized by alterations in energy metabolism, including mitochondrial dysfunction and a reduction in fatty acid (FA) oxidation rate, which is partially compensated by an increase in glucose utilization. Together, these changes lead to an impaired capacity to convert chemical energy into mechanical work. This has led to the concept that supporting cardiac energy conversion through metabolic interventions provides an important adjuvant therapy for heart failure. The potential success of such a therapy depends on whether the shift from FA towards glucose utilization should be considered beneficial or detrimental, a question still incompletely resolved. In this review, the current status of the literature is evaluated and possible causes of observed discrepancies are discussed. It is cautiously concluded that for the failing heart, from a therapeutic point of view, it is preferable to further stimulate glucose oxidation rather than to normalize substrate metabolism by stimulating FA utilization. Whether this also applies to the pre-stages of cardiac failure remains to be established.
Similar articles
-
Heart spotting.Basic Res Cardiol. 2008 May;103(3):228-31. doi: 10.1007/s00395-008-0698-z. Epub 2008 Feb 15. Basic Res Cardiol. 2008. PMID: 18274799
-
Decreased rates of substrate oxidation ex vivo predict the onset of heart failure and contractile dysfunction in rats with pressure overload.Cardiovasc Res. 2010 Jun 1;86(3):461-70. doi: 10.1093/cvr/cvp414. Epub 2009 Dec 24. Cardiovasc Res. 2010. PMID: 20035032
-
Energetic myocardial metabolism and oxidative stress: let's make them our friends in the fight against heart failure.Biomed Pharmacother. 2010 Mar;64(3):203-7. doi: 10.1016/j.biopha.2009.10.002. Epub 2009 Nov 13. Biomed Pharmacother. 2010. PMID: 19954925 Review.
-
Energy metabolism in heart failure and remodelling.Cardiovasc Res. 2009 Feb 15;81(3):412-9. doi: 10.1093/cvr/cvn301. Epub 2008 Nov 5. Cardiovasc Res. 2009. PMID: 18987051 Free PMC article. Review.
-
Myocardial substrate metabolism in the normal and failing heart.Physiol Rev. 2005 Jul;85(3):1093-129. doi: 10.1152/physrev.00006.2004. Physiol Rev. 2005. PMID: 15987803 Review.
Cited by
-
Glycolysis Metabolites and Risk of Atrial Fibrillation and Heart Failure in the PREDIMED Trial.Metabolites. 2021 May 11;11(5):306. doi: 10.3390/metabo11050306. Metabolites. 2021. PMID: 34064960 Free PMC article.
-
ADP compartmentation analysis reveals coupling between pyruvate kinase and ATPases in heart muscle.Biophys J. 2010 Jun 16;98(12):2785-93. doi: 10.1016/j.bpj.2010.03.025. Biophys J. 2010. PMID: 20550890 Free PMC article.
-
Inefficient Batteries in Heart Failure: Metabolic Bottlenecks Disrupting the Mitochondrial Ecosystem.JACC Basic Transl Sci. 2022 Jul 20;7(11):1161-1179. doi: 10.1016/j.jacbts.2022.03.017. eCollection 2022 Nov. JACC Basic Transl Sci. 2022. PMID: 36687274 Free PMC article. Review.
-
Elevated exhaled acetone concentration in stage C heart failure patients with diabetes mellitus.BMC Cardiovasc Disord. 2017 Nov 16;17(1):280. doi: 10.1186/s12872-017-0713-0. BMC Cardiovasc Disord. 2017. PMID: 29145814 Free PMC article.
-
Attenuation of Adverse Postinfarction Left Ventricular Remodeling with Empagliflozin Enhances Mitochondria-Linked Cellular Energetics and Mitochondrial Biogenesis.Int J Mol Sci. 2021 Dec 31;23(1):437. doi: 10.3390/ijms23010437. Int J Mol Sci. 2021. PMID: 35008865 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical